A Clinicopathological Diagnostic and Therapeutic Approach to Cytolytic Vaginosis: An Extremely Rare Entity that may Mimic Vulvovaginal Candidiasis
- PMID: 34321775
- PMCID: PMC8280860
- DOI: 10.4103/JOC.JOC_169_20
A Clinicopathological Diagnostic and Therapeutic Approach to Cytolytic Vaginosis: An Extremely Rare Entity that may Mimic Vulvovaginal Candidiasis
Abstract
Objectives: Cytolytic vaginosis is a very rare entity that may be clinically misdiagnosed as vulvovaginal candidiasis. The aim of this study was to determine the incidence of cytolytic vaginosis in patients displaying symptoms similar to vulvovaginal candidiasis and to develop a clinicopathological diagnostic and therapeutic approach.
Materials and methods: In total, 3000 cervical smear samples were evaluated at our center between 2015 and 2018. Patients whose PAP smears demonstrated significant epithelial cytolysis, naked nuclei, excessive increase in lactobacilli population, absent or minimal neutrophils and no microorganisms were subjected to a symptom assessment questionnaire and had their vaginal pHs measured. They were classified into two groups according to their complaints, symptoms and vaginal pHs: Cytolytic vaginosis and Asymptomatic intravaginal lactobacillus overgrowth. A standardized NaHCO3 Sitz bath therapy was applied to the cytolytic vaginosis group.
Results: Fifty-three of the patients (1.7%) were diagnosed as cytolytic vaginosis. After Sitz bath therapy, there was a statistically significant decrease in the cytolysis and lactobacillus scores of the patients. Vaginal discharge of 43 (81%) patients ceased completely while that of the remaining 10 (19%) patients decreased after the therapy. The improvement was statistically significant (P < 0.001). There was a complete resolution in 28 (96%) patients with severe; and in 21 (94%) patients with intermediate vaginal discomfort, after the therapy. Dyspareunia was resolved in 35 (97%) patients (P < 0.001).
Conclusion: Cytolytic vaginosis is a rare entity that can be diagnosed with the help of cytopathology and has a therapy based on the modulation microbiota by decreasing the vaginal pH.
Keywords: Bacterial; PAP smear; candidiasis; cytolytic vaginosis; lactobacillus; vulvovaginal.
Copyright: © 2021 Journal of Cytology.
Conflict of interest statement
There are no conflicts of interest.
Figures

Similar articles
-
Vaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: A non-targeted LC-MS pilot study.PLoS One. 2018 Aug 22;13(8):e0202401. doi: 10.1371/journal.pone.0202401. eCollection 2018. PLoS One. 2018. PMID: 30133508 Free PMC article. Clinical Trial.
-
Cytolytic vaginosis: misdiagnosed as candidal vaginitis.Infect Dis Obstet Gynecol. 2004;12(1):13-6. doi: 10.1080/10647440410001672139. Infect Dis Obstet Gynecol. 2004. PMID: 15460190 Free PMC article.
-
Cytolytic vaginosis: examination of 2947 vaginal smears.Cent Eur J Public Health. 2003 Mar;11(1):23-4. Cent Eur J Public Health. 2003. PMID: 12690799
-
Vaginitis.Am Fam Physician. 2011 Apr 1;83(7):807-15. Am Fam Physician. 2011. PMID: 21524046 Review.
-
Evaluation of vaginal complaints.JAMA. 2004 Mar 17;291(11):1368-79. doi: 10.1001/jama.291.11.1368. JAMA. 2004. PMID: 15026404 Review.
Cited by
-
Recent Advances in Presentation, Diagnosis and Treatment for Mixed Vaginitis.Front Cell Infect Microbiol. 2021 Nov 2;11:759795. doi: 10.3389/fcimb.2021.759795. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34796129 Free PMC article. Review.
-
Scoping review of cytolytic vaginosis literature.PLoS One. 2023 Jan 26;18(1):e0280954. doi: 10.1371/journal.pone.0280954. eCollection 2023. PLoS One. 2023. PMID: 36701339 Free PMC article.
-
Roles of the Microbiota of the Female Reproductive Tract in Gynecological and Reproductive Health.Microbiol Mol Biol Rev. 2022 Dec 21;86(4):e0018121. doi: 10.1128/mmbr.00181-21. Epub 2022 Oct 12. Microbiol Mol Biol Rev. 2022. PMID: 36222685 Free PMC article. Review.
References
-
- Osset J, Garcia E, Bartolome RM, Andreu A. Role of lactobacillus as protector against vaginal candidiasis. Med Clin (Barc) 2001;22:285–8. - PubMed
-
- Reis AJ. Treatment of vaginal infections: Candidiasis, bacterial vaginosis, and trichomoniasis. J Am Pharma Assoc (Wash) 1997;37:563–9. - PubMed
-
- Cullins VE, Dominguez L, Guberski T, Secor M, Wysocki SR. Treating vaginitis. Nurse Pract. 1999;24:46. - PubMed
-
- Schmid GP. The epidemiology of bacterial vaginosis. Int J Gynecol Obstet. 1999;67(Suppl 1):S17–20. - PubMed
-
- Mashburn J. Etiology, diagnosis, and management of vaginitis. J Midwifery Womens Health. 2006;51:423–30. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials